AxonDx
AXON Dx develops instruments and reagents for the rapid, minimally invasive analysis of circulating tumor cells (CTCs) shed by primary and metastatic tumors. Their tools aim to make hunting for rare cells, such as CTCs or circulating endothelial cells, a simple diagnostic test. They offer enhanced scanning optical systems powered by artificial intelligence and state-of-the-art biomarkers. Customized reagents can also be made and delivered quickly. Their technology enables researchers to identify and count CTCs in a patient's sample with a simple blood draw.
AxonDx
AXON Dx develops instruments and reagents for the rapid, minimally invasive analysis of circulating tumor cells (CTCs) shed by primary and metastatic tumors. Their tools aim to make hunting for rare cells, such as CTCs or circulating endothelial cells, a simple diagnostic test. They offer enhanced scanning optical systems powered by artificial intelligence and state-of-the-art biomarkers. Customized reagents can also be made and delivered quickly. Their technology enables researchers to identify and count CTCs in a patient's sample with a simple blood draw.